Back to search
Fetal-Maternal Hemorrhage
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fetal-Maternal Hemorrhage trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fetal-Maternal Hemorrhage trials you may qualify forThe primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pr…
Postpartum hemorrhage and birth asphyxia are the leading causes of maternal and neonatal mortalities worldwide. Prevention and adequate treatment are, therefore…
This study adopted a single-center, prospective, observational study design. A consecutive cohort of pregnant and postpartum women who met the inclusion criteri…
This a open, prospective, multicenter, single-arm, phase III study for clinical assessment of anti-Rh immunoglobulin (KamRho-D®) in Rh and Coombs negative women…
The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.